glucarpidase
Indication: Rescue treatment for delayed methotrexate elimination and toxicity after high-dose methotrexate therapy
Interactive glucarpidase rescue PK/PD simulator based on Kimura et al. (2023), modeling methotrexate decline, rebound, and dose-selection thresholds after high-dose methotrexate therapy.
Drug Overview
Clinical Context
- Molecular Target
- Methotrexate plasma concentration
- Drug Class
- Enzyme rescue therapy
- Therapeutic Area
- Oncology supportive care
- Indication
- Rescue treatment for delayed methotrexate elimination and toxicity after high-dose methotrexate therapy
- Route of Administration
- IV methotrexate infusion + IV glucarpidase rescue
Model Information
- Model Type
- Two-compartment PK/PD with modified Michaelis-Menten rescue
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for glucarpidase allows you to explore concentration-time profiles under different dosing scenarios. The underlying Two-compartment PK/PD with modified Michaelis-Menten rescue model characterizes the pharmacokinetics of this enzyme rescue therapy following iv methotrexate infusion + iv glucarpidase rescue administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration). The pharmacodynamic component links drug exposure to therapeutic or safety endpoints.
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the glucarpidase PK simulator?
This is a free, interactive pharmacokinetic simulator for glucarpidase used in Rescue treatment for delayed methotrexate elimination and toxicity after high-dose methotrexate therapy. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does glucarpidase belong to?
glucarpidase is classified as a Enzyme rescue therapy that targets Methotrexate plasma concentration. It is used in the Oncology supportive care therapeutic area.
What route of administration does this model simulate?
This simulator models IV methotrexate infusion + IV glucarpidase rescue administration of glucarpidase. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a Two-compartment PK/PD with modified Michaelis-Menten rescue model. PK/PD models link drug concentrations to pharmacological effects, allowing exploration of exposure-response relationships.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Ready to Simulate?
Launch the glucarpidase simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community